Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (121-130 of 271) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved SurvivalNatalie Vandeven, Christopher W Lewis, Vladimir Makarov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 12, 2024
Genomic Landscape of Superficial Malignant Peripheral Nerve Sheath TumorJohn L McAfee, Tyler J Alban, Vladimir Makarov, et al.
Neuro-Oncology|March 26, 2014
Transcriptional diversity of long-term glioblastoma survivorsNaamit K Gerber, Anuj Goenka, Sevin Turcan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapyPatrick G Morris, Anne S Reiner, Olga Rosenvald Szenberg, et al.
Oncotarget|December 15, 2015
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapyGerald Goh, Trent Walradt, Vladimir Markarov, et al.
Oral Oncology|July 4, 2020
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinomaEvangelia Katsoulakis, Yao Yu, Aditya P Apte, et al.
Oncotarget|October 1, 2013
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograftAlexandra Borodovsky, Vafi Salmasi, Sevin Turcan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2014
Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesisBerenice Ortiz, Armida W M Fabius, Wei H Wu, et al.
Journal of Neuro-Oncology|August 27, 2015
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastasesZachary A Kohutek, Yoshiya Yamada, Timothy A Chan, et al.
Nature|November 14, 2017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapyMarta Łuksza, Nadeem Riaz, Vladimir Makarov, et al.
Pageof 28

Showing results (121-130 of 271) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved SurvivalNatalie Vandeven, Christopher W Lewis, Vladimir Makarov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 12, 2024
Genomic Landscape of Superficial Malignant Peripheral Nerve Sheath TumorJohn L McAfee, Tyler J Alban, Vladimir Makarov, et al.
Neuro-Oncology|March 26, 2014
Transcriptional diversity of long-term glioblastoma survivorsNaamit K Gerber, Anuj Goenka, Sevin Turcan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapyPatrick G Morris, Anne S Reiner, Olga Rosenvald Szenberg, et al.
Oncotarget|December 15, 2015
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapyGerald Goh, Trent Walradt, Vladimir Markarov, et al.
Oral Oncology|July 4, 2020
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinomaEvangelia Katsoulakis, Yao Yu, Aditya P Apte, et al.
Oncotarget|October 1, 2013
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograftAlexandra Borodovsky, Vafi Salmasi, Sevin Turcan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2014
Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesisBerenice Ortiz, Armida W M Fabius, Wei H Wu, et al.
Journal of Neuro-Oncology|August 27, 2015
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastasesZachary A Kohutek, Yoshiya Yamada, Timothy A Chan, et al.
Nature|November 14, 2017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapyMarta Łuksza, Nadeem Riaz, Vladimir Makarov, et al.
Pageof 28